Published in
Springer Nature [academic journals on nature.com], Leukemia, 2(32), p. 323-331, 2017
DOI: 10.1038/leu.2017.216
Links
Tools
The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis
Journal article published in 2017 by
P. Garrido Castro,
E. H. J. van Roon,
G. te Kronnie,
S. S. Pinhanços,
L. Trentin 
,
P. Schneider,
M. Kerstjens,
O. Heidenreich,
R. Pieters,
R. W. Stam
,
P. Schneider,
M. Kerstjens,
O. Heidenreich,
R. Pieters,
R. W. Stam
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 